Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report)’s share price hit a new 52-week high during trading on Monday . The company traded as high as $9.45 and last traded at $9.45, with a volume of 536 shares traded. The stock had previously closed at $9.05.
Aspen Pharmacare Price Performance
The company has a quick ratio of 2.66, a current ratio of 3.64 and a debt-to-equity ratio of 0.36. The business has a 50 day simple moving average of $8.87 and a 200-day simple moving average of $8.10.
About Aspen Pharmacare
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over?the?counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Featured Stories
- Five stocks we like better than Aspen Pharmacare
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
